• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antibiotics (Basel) . Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia

tetano

Editor, Senior Moderator
Antibiotics (Basel)


. 2021 Mar 26;10(4):350.
doi: 10.3390/antibiotics10040350.
Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia


Raquel Carbonell[SUP] 1 [/SUP], Gerard Moreno[SUP] 1 [/SUP], Ignacio Mart?n-Loeches[SUP] 2 [/SUP], Frederic Gomez-Bertomeu[SUP] 3 [/SUP], Carolina Sarvis?[SUP] 3 [/SUP], Josep G?mez[SUP] 4 [/SUP], Mar?a Bod?[SUP] 5 [/SUP], Emili D?az[SUP] 6 [/SUP], Elisabeth Papiol[SUP] 7 [/SUP], Sandra Trefler[SUP] 1 [/SUP], Mercedes Nieto[SUP] 8 [/SUP], Angel Estella[SUP] 9 [/SUP], Mar?a Jim?nez Herrera[SUP] 10 [/SUP], Pablo Vidal Cort?s[SUP] 11 [/SUP], Juan Jos? Guardiola[SUP] 12 [/SUP], Jordi Sol?-Viol?n[SUP] 13 [/SUP], Alejandro Rodr?guez[SUP] 5 [/SUP]



Affiliations

Abstract

Background: Procalcitonin (PCT) and C-Reactive protein (CRP) are well-established sepsis biomarkers. The association of baseline PCT levels and mortality in pneumonia remains unclear, and we still do not know whether biomarkers levels could be related to the causative microorganism (GPC, GNB). The objective of this study is to address these issues. Methods: a retrospective observational cohort study was conducted in 184 Spanish ICUs (2009-2018). Results: 1608 patients with severe influenza pneumonia with PCT and CRP available levels on admission were included, 1186 with primary viral pneumonia (PVP) and 422 with bacterial Co-infection (BC). Those with BC presented higher PCT levels (4.25 [0.6-19.5] versus 0.6 [0.2-2.3]ng/mL) and CRP (36.7 [20.23-118] versus 28.05 [13.3-109]mg/dL) as compared to PVP (p < 0.001). Deceased patients had higher PCT (ng/mL) when compared with survivors, in PVP (0.82 [0.3-2.8]) versus 0.53 [0.19-2.1], p = 0.001) and BC (6.9 [0.93-28.5] versus 3.8 [0.5-17.37], p = 0.039). However, no significant association with mortality was observed in the multivariate analysis. The PCT levels (ng/mL) were significantly higher in polymicrobial infection (8.4) and GPC (6.9) when compared with GNB (1.2) and Aspergillus (1.7). The AUC-ROC of PCT for GPC was 0.67 and 0.32 for GNB. The AUROC of CRP was 0.56 for GPC and 0.39 for GNB. Conclusions: a single PCT/CRP value at ICU admission was not associated with mortality in severe influenza pneumonia. None of the biomarkers have enough discriminatory power to be used for predicting the causative microorganism of the co-infection.

Keywords: C-Reactive protein; Gram negative bacilli; Gram-positive cocci; mortality; pneumonia; procalcitonin.
 
Back
Top Bottom